Krebs Biochemicals (India) Analysis

Krebs Stock Analysis Notes

About 78.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 10.1. Krebs Biochemicals and last dividend was issued on the 14th of September 2005. To find out more about Krebs Biochemicals and contact Jitendra Shah at 91 91 2114 4984 or learn more at https://krebsbiochem.com.

Krebs Biochemicals and Investment Alerts

Krebs Biochemicals Thematic Classifications

Krebs Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Krebs Biochemicals's market, we take the total number of its shares issued and multiply it by Krebs Biochemicals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Krebs Profitablity

The company has Profit Margin (PM) of (0.37) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.3) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.3.

Management Efficiency

Krebs Biochemicals and has return on total asset (ROA) of (0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals' Total Current Assets are decreasing as compared to previous years. The Krebs Biochemicals' current Intangible Assets is estimated to increase to about 27.7 M, while Total Assets are projected to decrease to under 1.3 B.

Technical Drivers

As of the 22nd of November, Krebs Biochemicals secures the Mean Deviation of 1.88, risk adjusted performance of 0.0156, and Downside Deviation of 1.87. Krebs Biochemicals and technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.

Krebs Biochemicals and Price Movement Analysis

Krebs Biochemicals Outstanding Bonds

Krebs Biochemicals Predictive Daily Indicators

Krebs Biochemicals Forecast Models

Krebs Biochemicals' time-series forecasting models are one of many Krebs Biochemicals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Krebs Biochemicals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Krebs Biochemicals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Krebs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Krebs Biochemicals. By using and applying Krebs Stock analysis, traders can create a robust methodology for identifying Krebs entry and exit points for their positions.

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.